共 50 条
- [5] Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe Advances in Therapy, 2024, 41 : 331 - 348
- [7] Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab BioDrugs, 2016, 30 : 339 - 351